Tejnaksh Healthcare Limited is an India-based holding company, which is engaged in the healthcare services and pharmacies business. The Company is focused on the provision of hospital and healthcare services in Mumbai and other parts of Maharashtra. The Company operates through one segment: Health care services. The Company's domains include Multi-specialty Hospital, Super Specialty Hospital, Pathology Lab, research and development, Pharmaceuticals, Healthcare Equipment, Super Specialty Training Institutes, Stone Analysis Lab Education Institutes, Education Institutes, and Simulation Institute. Its Healthcare Equipment includes a stone manipulation simulator, Fluoroscopy guided simulator, an ultrasound guided perc simulator, Percutaneous Nephrolithotomy (PCNL) logic simulator, turp simulator, and a radiation-free perc simulator. It provides healthcare services at approximately 13 urology clinics, four urology hospitals, and two dental superspecialist clinics.As of 25 May 2026, Tejnaksh Healthcare Limited share price is ₹15.69. The stock opened at ₹14.71, compared to its previous close of ₹14.42. During today's trading session, Tejnaksh Healthcare Limited share price moved in the range of ₹14.71 to ₹15.69, with an average price of ₹15.20 for the day. Looking at its last 52-week, the stock has touched a low of ₹14.71 and a high of ₹15.69.
The market capitalization of Tejnaksh Healthcare Limited is ₹29 Crs, with a P/E ratio of 23.3 and a dividend yield of 0.00%.